Liu XH, Kirschenbaum A, Yao S, Liu G, Aaronson SA, Levine AC. Androgen-induced Wnt signaling in preosteoblasts promotes the growth of MDA-PCa-2b human prostate cancer cells. Cancer Res 2007; 67(12): 5747-5753.
Liu G, Bafico A, Aaronson SA. The mechanism of endogenous receptor activation functionally distinguishes prototype canonical and noncanonical Wnts. Molecular Cell Biology 2005; 25(9): 3475-3482.
Bafico A, Liu G, Goldin L, Harris V, Aaronson SA. An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell 2004; 6: 497-506.
Golan T, Yaniv A, Bafico A, Liu G, Gazit A. The human Frizzled 6 (HFz6) acts as a negative regulator of the canonical Wnt. beta-catenin signaling cascade. J Biol Chem 2004; 279(15): 14879-14888.
Liu G, Bafico A, Harris VK, Aaronson SA. A Novel Mechanism for Wnt activation of canonical signaling through LRP6 receptor. Molecular Cell Biology 2003; 23(16): 5825-5835.
Fang L, Li G, Liu G, Lee SW, Aaronson SA. p53 induction of heparin-binding EGF-like growth factor counteract p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades. EMBO J 2001; 20: 1931-1939.
Bafico A, Liu G, Yaniv A, Gazit A, Aaronson SA. Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nature Cell Biology 2001; 3: 683-686.
Liu G, Wu M, Levi G, Ferrari N. Down-regulation of the Diphthamide biosynthesis protein 2-like gene during retinoid-induced differentiation and apoptosis: implications against its tumor-suppressor activity. International J. Cancer 2000; 88(3): 356-362.
Liu G, Wu M, Levi G, Ferrari N. Growth inhibition of human cancer cells by all-trans retinoic acid and N-(4-hydroxyphenyl) retinamide: a possible mechanism via regulation of retinoids receptors. International J. Cancer 1998; 78: 248-254.